Hoshi Masato相关文献与解析，生知库 | 链接生命科学的每一步

Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3-Year J-Post-Marketing Surveillance

托法替尼治疗类风湿性关节炎患者发生重大不良心血管事件、恶性肿瘤和严重感染的风险因素：一项为期3年的上市后监测研究的事后分析

期刊:International Journal of Rheumatic Diseases

影响因子:2

doi:10.1111/1756-185x.70572

Yamaoka, Kunihiro; Hoshi, Masato; Endo, Yutaka; Hirano, Toshitaka

Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data

日本溃疡性结肠炎患者托法替尼上市后监测：安全性和有效性数据的最终报告

期刊:Journal of Gastroenterology

影响因子:5.5

doi:10.1007/s00535-025-02249-5

Matsuoka, Katsuyoshi; Motoya, Satoshi; Yamamoto, Takayuki; Matsuura, Minoru; Fujii, Toshimitsu; Shinzaki, Shinichiro; Mikami, Yohei; Arai, Shoko; Oshima, Junichi; Endo, Yutaka; Yuasa, Hirotoshi; Hoshi, Masato; Sato, Keiko; Hisamatsu, Tadakazu

Identifying Risk Factors of Major Adverse Cardiac Events in Patients With Ulcerative Colitis: A Retrospective Japanese Claims Data Analysis

溃疡性结肠炎患者发生重大不良心脏事件的风险因素识别：一项回顾性日本医疗保险数据分析

期刊:Journal of Gastroenterology and Hepatology

影响因子:3.4

doi:10.1111/jgh.16831

Takagi, Tomohisa; Xu, Linghua; Hoshi, Masato; Arai, Shoko

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis

用于治疗类风湿性关节炎的生物制剂中HLA-DR相关免疫原性风险的个体和群体水平变异性

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1377911

Sugiyama, Naonobu; Terry, Frances E; Gutierrez, Andres H; Hirano, Toshitaka; Hoshi, Masato; Mizuno, Yasushi; Martin, William; Yasunaga, Shin'ichiro; Niiro, Hiroaki; Fujio, Keishi; De Groot, Anne S

Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan

日本真实世界研究中类风湿性关节炎患者发生重大不良心血管事件和恶性肿瘤的风险因素

期刊:International Journal of Rheumatic Diseases

影响因子:2

doi:10.1111/1756-185X.15448

Yamaoka, Kunihiro; Sugiyama, Naonobu; Hoshi, Masato; Jo, Joo-Young; Shin, Kichul; Hirano, Toshitaka

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan

日本中重度溃疡性结肠炎初治患者中，托法替尼与生物制剂疗效比较的成本效益分析

期刊:Pharmacoeconomics

影响因子:4.6

doi:10.1007/s40273-023-01254-x

Kobayashi, Taku; Hoshi, Masato; Yuasa, Akira; Arai, Shoko; Ikeda, Mitsunobu; Matsuda, Hiroyuki; Kim, Seok-Won; Hibi, Toshifumi

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis

日本溃疡性结肠炎患者住院感染、带状疱疹和恶性肿瘤的发生率：一项基于行政健康索赔数据库的分析

期刊:Intestinal Research

影响因子:3.9

doi:10.5217/ir.2021.00154

Matsuoka, Katsuyoshi; Togo, Kanae; Yoshii, Noritoshi; Hoshi, Masato; Arai, Shoko

A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys.

用于解析人类肾脏分子解剖结构和病理生理学的单核RNA测序流程

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-019-10861-2

Lake Blue B, Chen Song, Hoshi Masato, Plongthongkum Nongluk, Salamon Diane, Knoten Amanda, Vijayan Anitha, Venkatesh Ramakrishna, Kim Eric H, Gao Derek, Gaut Joseph, Zhang Kun, Jain Sanjay

Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation

脑心肌炎病毒接种后病毒性心肌炎中心脏和血清半乳糖凝集素-3的时间进程分析

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0210971

Noguchi, Kei; Tomita, Hiroyuki; Kanayama, Tomohiro; Niwa, Ayumi; Hatano, Yuichiro; Hoshi, Masato; Sugie, Shigeyuki; Okada, Hideshi; Niwa, Masayuki; Hara, Akira

Health-Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan

日本白癜风患者的健康相关生活质量和心理负担

Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3-Year J-Post-Marketing Surveillance

托法替尼治疗类风湿性关节炎患者发生重大不良心血管事件、恶性肿瘤和严重感染的风险因素：一项为期3年的上市后监测研究的事后分析

Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data

日本溃疡性结肠炎患者托法替尼上市后监测：安全性和有效性数据的最终报告

Identifying Risk Factors of Major Adverse Cardiac Events in Patients With Ulcerative Colitis: A Retrospective Japanese Claims Data Analysis

溃疡性结肠炎患者发生重大不良心脏事件的风险因素识别：一项回顾性日本医疗保险数据分析

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis

用于治疗类风湿性关节炎的生物制剂中HLA-DR相关免疫原性风险的个体和群体水平变异性

Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real-World Setting in Japan

日本真实世界研究中类风湿性关节炎患者发生重大不良心血管事件和恶性肿瘤的风险因素

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan

日本中重度溃疡性结肠炎初治患者中，托法替尼与生物制剂疗效比较的成本效益分析

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis

日本溃疡性结肠炎患者住院感染、带状疱疹和恶性肿瘤的发生率：一项基于行政健康索赔数据库的分析

A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys.

用于解析人类肾脏分子解剖结构和病理生理学的单核RNA测序流程

Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation

脑心肌炎病毒接种后病毒性心肌炎中心脏和血清半乳糖凝集素-3的时间进程分析